Corrigendum | Open Access
Corrigendum to “Risk Factors for Fracture in Diabetes: The Canadian Multicentre Osteoporosis Study”
In the article titled “Risk Factors for Fracture in Diabetes: The Canadian Multicentre Osteoporosis Study” , there was an error regarding the FRAX® tool, which should be clarified as follows.
The article notes: “The WHO fracture risk assessment tool (FRAX), a commonly used fracture prediction tool, has been found to underestimate fracture risk in the diabetic population .” However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations . The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but treatment guidelines must undergo a formal process before they can be endorsed by the WHO.
- L. Fraser, A. Papaioannou, J. D. Adachi, J. Ma, and L. Thabane, “Risk factors for fracture in diabetes: the canadian multicentre osteoporosis study,” ISRN Epidemiology, vol. 2013, Article ID 249874, 6 pages, 2013.
- N. Ford, S. L. Norris, and S. R. Hill, “Clarifying WHO’s position on the FRAX® tool for fracture prediction,” Bulletin of the World Health Organization, vol. 94, no. 12, article 862, 2016.
Copyright © 2017 Lisa-Ann Fraser et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.